Cancer vaccine - CEL-SCI/National Cancer Institute
Alternative Names: Breast cancer vaccine - CEL-SCI/National Cancer Institute; Prostate cancer vaccine - CEL-SCI/National Cancer InstituteLatest Information Update: 31 Dec 2021
At a glance
- Originator CEL-SCI Corporation
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Breast cancer; Prostate cancer
Most Recent Events
- 07 Apr 2003 Discontinued - Preclinical for Breast cancer in USA (Parenteral)
- 07 Apr 2003 Discontinued - Preclinical for Prostate cancer in USA (Parenteral)
- 07 Apr 2003 No development reported - Preclinical for Breast cancer in USA (Parenteral)